IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products

Stock News

May 22

IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1186724819"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186724819\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186724819?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-22 21:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186724819","market":"hk","top_or_hot":-1,"title":"IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products","media":"Stock News","content":"<p>IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-22 21:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"","article_id":"1186724819","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186724819","pubTimestamp":1779456509,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0028":"国家队","000166":"申万宏源","BK0276":"资本市场","06806":"申万宏源","BK0183":"MSCI概念","BK1564":"中资券商股","BK0188":"融资融券","BK1161":"生物科技","BK0012":"证金概念","BK1147":"投资银行业与经纪业","01541":"宜明昂科-B"},"translate_title":"IMMUNEONCO-B(01541)赎回2.05亿港元申万产品及认购2.12亿港元申万宏源理财产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000166":1,"01541":1,"06806":1},"content_text":"IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}